IMS biometrics
market leader Bioscrypt couldn't use their market position to
turn a profit in the second quarter, unfortunately. They brought in $4.8 million over the three months ending June 30, but that was $600,000 less than the same quarter last year, and it accounted for a $3.9 milion loss. Some of that can be attributed to the
A4 Vision buy, which did bring some cool technology, but it's enough of a concern that Bioscrypt has axed 10 percent of its workforce and brought on new CFO Stephen McDonald. This can't be the the way
new CEO Robert Douglas wanted to start his tenure.
Comments